ACVBP
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ACVBP, covering 2017-03-13 to 2018-08-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma [Phase 2]